The aim of this study is to investigate the seroprevalence of hepatitis C virus infection among different populations in the Hsin-Chu area. From July 1994 to June 1996, a total of 890 serum samples, including 589 serum samples from HaKKa Chinese, 33 serum samples from MinNan Chinese and 286 serum samples from aborigines, were tested for anti-hepatitis C antibodies by means of a 2nd generation enzyme immunoassay. Results showed that the overall seropositive rate was 7.6%. The seroposivive rate was 12.1% for the MinNan group, 8.0%for the HaKKa group and 6.3% for the aboriginal group (ρ>0.05). The seroposivive rate was 16.1% in the age group over 80 years old, 15.2% in the 70 to 79 year age group, 20.9% in the 60 to 69 year age group, 17.3% in the 50 to 59 year age group, 3.8% in the 40 to 49 year age group, 8.9% in the 30to 39 year age group, 5.0% in the 20 to 29 year age group, 1.0% in the 10 to 19year age group and 0.0% in the 0 to 9 year age group. There is a slight increase with age. No significant difference in seropositive rates was observed between males (7.4%) and females ( 8.0%) (ρ>0.05). No significant difference in seropositive rates was observed in people living north or south of the You-Row river (ρ>0.05). A review of the history of 66 seropositive persons revealed that the percentages of blood transfusion, frequent medical injections and hemodialysis were 65.2%, 43.9% and 6.1%, respectively.
The aim of this study is to investigate the seroprevalence of hepatitis C virus infection among different populations in the Hsin-Chu area. From July 1994 to June 1996, a total of 890 serum samples, including 589 serum samples from HaKKa Chinese, 33 serum samples from MinNan Chinese and 286 serum samples from aborigines, were tested for anti-hepatitis C antibodies by means of a 2nd generation enzyme immunoassay. Results showed that the overall seropositive rate was 7.6%. The seroposivive rate was 12.1% for the MinNan group, 8.0%for the HaKKa group and 6.3% for the aboriginal group (ρ>0.05). The seroposivive rate was 16.1% in the age group over 80 years old, 15.2% in the 70 to 79 year age group, 20.9% in the 60 to 69 year age group, 17.3% in the 50 to 59 year age group, 3.8% in the 40 to 49 year age group, 8.9% in the 30to 39 year age group, 5.0% in the 20 to 29 year age group, 1.0% in the 10 to 19year age group and 0.0% in the 0 to 9 year age group. There is a slight increase with age. No significant difference in seropositive rates was observed between males (7.4%) and females ( 8.0%) (ρ>0.05). No significant difference in seropositive rates was observed in people living north or south of the You-Row river (ρ>0.05). A review of the history of 66 seropositive persons revealed that the percentages of blood transfusion, frequent medical injections and hemodialysis were 65.2%, 43.9% and 6.1%, respectively.
In order to continuously optimize website functionality and user experience, this website uses cookies analysis technology for website operation, analysis, and personalized services.
If you continue to browse this website, it means you agree to the use of cookies on this website.